Laboratory Medicine ›› 2021, Vol. 36 ›› Issue (1): 111-113.DOI: 10.3969/j.issn.1673-8640.2021.01.023
Previous Articles Next Articles
Received:2020-01-09
Online:2021-01-30
Published:2021-02-05
CLC Number:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.shjyyx.com/EN/10.3969/j.issn.1673-8640.2021.01.023
| 抗菌药物 类别 | 种类数/种 | 药物名称 |
|---|---|---|
| 青霉素类 | 2 | 美洛西林-舒巴坦、哌拉西林-他唑 巴坦 |
| 头孢菌素类 | 8 | 头孢替安、头孢曲松、头孢呋辛、 头孢美唑、头孢替唑、头孢唑 林、头孢哌酮-舒巴坦、头孢孟多 酯钠 |
| 碳青酶烯类 | 3 | 美罗培南、亚胺培南-西司他丁钠、 厄他培南 |
| 单环类 | 1 | 氨曲南 |
| 氨基糖苷类 | 2 | 硫酸异帕米星、硫酸依替米星 |
| 大环内酯类 | 2 | 红霉素、阿奇霉素 |
| 喹诺酮类 | 3 | 环丙沙星、左氧氟沙星、莫西沙星 |
| 多肽类 | 1 | 万古霉素 |
| 硝基咪唑类 | 3 | 甲硝唑、奥硝唑、替硝唑 |
| 恶唑酮类 | 1 | 利奈唑胺 |
| 抗菌药物 类别 | 种类数/种 | 药物名称 |
|---|---|---|
| 青霉素类 | 2 | 美洛西林-舒巴坦、哌拉西林-他唑 巴坦 |
| 头孢菌素类 | 8 | 头孢替安、头孢曲松、头孢呋辛、 头孢美唑、头孢替唑、头孢唑 林、头孢哌酮-舒巴坦、头孢孟多 酯钠 |
| 碳青酶烯类 | 3 | 美罗培南、亚胺培南-西司他丁钠、 厄他培南 |
| 单环类 | 1 | 氨曲南 |
| 氨基糖苷类 | 2 | 硫酸异帕米星、硫酸依替米星 |
| 大环内酯类 | 2 | 红霉素、阿奇霉素 |
| 喹诺酮类 | 3 | 环丙沙星、左氧氟沙星、莫西沙星 |
| 多肽类 | 1 | 万古霉素 |
| 硝基咪唑类 | 3 | 甲硝唑、奥硝唑、替硝唑 |
| 恶唑酮类 | 1 | 利奈唑胺 |
| 抗菌药物 | 累计计量/g | 用药天数/d | DDD值 | DDDs | DUI |
|---|---|---|---|---|---|
| 头孢美唑 | 1 316.0 | 299 | 1.50 | 877.3 | 2.93 |
| 莫西沙星 | 172.0 | 405 | 0.40 | 430.0 | 1.06 |
| 阿奇霉素 | 164.5 | 315 | 0.50 | 329.0 | 1.04 |
| 哌拉西林-他唑巴坦 | 4 392.0 | 357 | 13.50 | 325.3 | 0.91 |
| 左氧氟沙星 | 132.5 | 238 | 0.50 | 265.0 | 1.11 |
| 美洛西林-舒巴坦 | 1 035.0 | 147 | 6.75 | 153.3 | 1.04 |
| 头孢替安 | 144.5 | 48 | 1.00 | 144.5 | 3.01 |
| 头孢曲松 | 246.0 | 54 | 2.00 | 123.0 | 2.28 |
| 美罗培南 | 168.0 | 122 | 1.50 | 112.0 | 0.92 |
| 头孢呋辛 | 195.0 | 60 | 2.25 | 86.7 | 1.45 |
| 抗菌药物 | 累计计量/g | 用药天数/d | DDD值 | DDDs | DUI |
|---|---|---|---|---|---|
| 头孢美唑 | 1 316.0 | 299 | 1.50 | 877.3 | 2.93 |
| 莫西沙星 | 172.0 | 405 | 0.40 | 430.0 | 1.06 |
| 阿奇霉素 | 164.5 | 315 | 0.50 | 329.0 | 1.04 |
| 哌拉西林-他唑巴坦 | 4 392.0 | 357 | 13.50 | 325.3 | 0.91 |
| 左氧氟沙星 | 132.5 | 238 | 0.50 | 265.0 | 1.11 |
| 美洛西林-舒巴坦 | 1 035.0 | 147 | 6.75 | 153.3 | 1.04 |
| 头孢替安 | 144.5 | 48 | 1.00 | 144.5 | 3.01 |
| 头孢曲松 | 246.0 | 54 | 2.00 | 123.0 | 2.28 |
| 美罗培南 | 168.0 | 122 | 1.50 | 112.0 | 0.92 |
| 头孢呋辛 | 195.0 | 60 | 2.25 | 86.7 | 1.45 |
| 合用类别 | 例数 | 联合用药类别 | 累计例数 |
|---|---|---|---|
| 大环内酯类合用 | 74 | β-内酰胺类 | 60 |
| 碳青酶烯类 | 8 | ||
| 氨基糖苷类 | 4 | ||
| 喹诺酮类 | 2 | ||
| 喹诺酮类合用 | 66 | β-内酰胺类 | 48 |
| 碳青酶烯类 | 8 | ||
| 氨基糖苷类 | 4 | ||
| 噁唑烷酮类 | 4 | ||
| 糖肽类 | 2 | ||
| β-内酰胺类合用 | 20 | β-内酰胺类 | 10 |
| 氨基糖苷类 | 6 | ||
| 糖肽类 | 3 | ||
| 噁唑烷酮类 | 1 |
| 合用类别 | 例数 | 联合用药类别 | 累计例数 |
|---|---|---|---|
| 大环内酯类合用 | 74 | β-内酰胺类 | 60 |
| 碳青酶烯类 | 8 | ||
| 氨基糖苷类 | 4 | ||
| 喹诺酮类 | 2 | ||
| 喹诺酮类合用 | 66 | β-内酰胺类 | 48 |
| 碳青酶烯类 | 8 | ||
| 氨基糖苷类 | 4 | ||
| 噁唑烷酮类 | 4 | ||
| 糖肽类 | 2 | ||
| β-内酰胺类合用 | 20 | β-内酰胺类 | 10 |
| 氨基糖苷类 | 6 | ||
| 糖肽类 | 3 | ||
| 噁唑烷酮类 | 1 |
| [1] | 韩静静,曹霞,周晨亮,等. 多重耐药菌导致呼吸机相关性肺炎的危险因素及病原菌分析[J]. 医药导报,2019,38(10):1335-1338. |
| [2] | 中华医学会呼吸病学分会. 社区获得性肺炎诊断和治疗指南[J]. 中华结核和呼吸杂志,2006,29(10):651-655 |
| [3] | 陈新谦,金有豫,汤光. 新编药物学(第16版) [M]. 北京:人民卫生出版社,2007. |
| [4] | 张智琪,陈孟莉. 2011—2013年我院常用麻醉药品应用分析[J]. 中国药物应用与监测,2015,12(4):242-245. |
| [5] | 宗春光,李军,陶晓明,等. 老年患者广泛耐药鲍曼不动杆菌血行感染及死亡危险因素[J]. 中国老年学杂志,2019,39(18):4505-4507. |
| [6] | CHO J C,ZMARLICKA M T,SHAEER K M,et al.Meropenem/vaborbactam,the first carbapenem/β-lactamase inhibitor combination[J]. Ann Pharmacother,2018,52(8):769-779. |
| [7] | WU G,CHEON E.Meropenem-vaborbactam for the treatment of complicated urinary tract infections including acute pyelonephritis[J]. Expert Opin Pharmacother,2018,19(13):1495-1502. |
| [8] | YU Z,PANG X,WU X,et al.Clinical outcomes of prolonged infusion(extended infusion or continuous infusion)versus intermittent bolus of meropenem in severe infection:a meta-analysis[J]. PLoS One,2018,13(7):e0201667. |
| [9] | 汤雨晴,叶倩,郑维义. 抗生素类药物的研究现状和进展[J]. 国外医药(抗生素分册),2019,40(4):295-301. |
| [10] | ZHAO W,WANG B,YU G.Antibiotic resistance genes in China:occurrence,risk,and correlation among different parameters[J]. Environ Sci Pollut Res Int,2018,25(22) :21467-21482. |
| [11] | 陈旎旎,吴艳琴,余文浩. 氟喹诺酮类抗菌药物治疗卒中相关性肺炎的安全性评价[J]. 中国实用医药,2019,14(24):88-89. |
| [12] | 孙晓娈,王莹,李歆. 江苏省47家三级医院抗菌药物利用与趋势分析[J]. 中国现代应用药学,2019,36(19):2478-2484. |
| [13] | 许书花,冯锦辉,黄韫,等. 我院2015~2016年辅助用药情况分析[J]. 海峡药学,2017,29(7):248-250. |
| [1] | FAN Lieying. Research status and application prospects of biomarkers for membranous nephropathy [J]. Laboratory Medicine, 2023, 38(12): 1111-1114. |
| [2] | SUN Lincheng, LI Jianfeng, CHENG Weili, JI Panyun. Roles of anti-PLA2R IgG4 antibody and PLA2R IgG4/IgG ratio in primary membranous nephropathy [J]. Laboratory Medicine, 2023, 38(12): 1115-1120. |
| [3] | LIU Qingyang, YUAN Jianming, XIA Jinjun, JIANG Fengying, WANG Qiubo, WANG Xiaoming. CXCL9 as a potential diagnostic marker of rheumatoid arthritis based on GEO database and experimental verification [J]. Laboratory Medicine, 2023, 38(12): 1121-1129. |
| [4] | YANG Xiao, LI Enling, WU Lixia, DAI Yingxin, WANG Zhiqing, HUANG Hao, ZHENG Bing. Influence of cytoplasmic antinuclear antibody on indirect immunofluorescence assay based antineutrophil cytoplasmic antibody determination [J]. Laboratory Medicine, 2023, 38(12): 1135-1140. |
| [5] | XIANG Jin, LIU Aiping, HU Yao, WU Zhiyuan, CAO Guojun, GUAN Ming. ANA profiles in COVID-19 patients and influence of serum heat-inactivation on ANA determination [J]. Laboratory Medicine, 2023, 38(12): 1141-1146. |
| [6] | CHENG Yu, XU Zhen, LU Liu, DING Menglei, YU Shanshan, ZONG Ming, FAN Lieying. Expression and risk factors of anti-ACE-2 antibody in serum of patients with COVID-19 [J]. Laboratory Medicine, 2023, 38(12): 1147-1152. |
| [7] | . [J]. Laboratory Medicine, 2023, 38(12): 1153-1156. |
| [8] | . [J]. Laboratory Medicine, 2023, 38(12): 1157-1159. |
| [9] | WANG Hongling, LIU Mengna, BAI Ping, LIAO Huanjin. Risk factors of relapse following allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia [J]. Laboratory Medicine, 2023, 38(12): 1160-1166. |
| [10] | YANG Xilan, WANG Jinyu, LIU Shuyu, ZHAN Yiyang, LIU Jing, JIA Jian. Correlation between hyperlipidemia and endothelial microparticles in elderly patients from Gulou Community in Nanjing [J]. Laboratory Medicine, 2023, 38(12): 1167-1172. |
| [11] | DAI Fangfang, LU Xinxin, YU Yanhua, CHEN Ming, SUN Guizhen. Analysis of Mycobacterium infection in HIV/AIDS patients [J]. Laboratory Medicine, 2023, 38(12): 1173-1176. |
| [12] | GU Yu, LIANG Xiaoyan, MA Shenghui, TONG Na, CHENG Mingyan, YAN Zejun. Expression and near-term prognostic predictive value of plasma biomarkers in chronic kidney disease patients with thromboembolism [J]. Laboratory Medicine, 2023, 38(12): 1177-1182. |
| [13] | . [J]. Laboratory Medicine, 2023, 38(12): 1183-1185. |
| [14] | . [J]. Laboratory Medicine, 2023, 38(12): 1186-1190. |
| [15] | . [J]. Laboratory Medicine, 2023, 38(12): 1191-1194. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||
